Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No-Reflow”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07155395
What this trial is testing

Inflammatory and Hematological Indices in Diabetic STEMI Patients Undergoing Primary PCI

Who this might be right for
STEMIDiabete Mellitus
Assiut University 1,000
Not applicableUnknownNCT03591991
What this trial is testing

Empagliflozin on Cardiac-renal Injury in Patients With STEAMI Patients After Primary PCI

Who this might be right for
Reperfusion Injury, Myocardial
Chinese PLA General Hospital 128
Not applicableUnknownNCT02818127
What this trial is testing

Assessment Of Total Coronary Circulation Time Using TIMI Frame Count Method (TCCT-TIMI)

Who this might be right for
Coronary AngiographyCoronary Artery DiseaseCoronary Artery Ectasia+2 more
Vascular and Molecular Cardiology Society 2,000
Post-approval studies (Phase 4)Looking for participantsNCT07536802
What this trial is testing

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

Who this might be right for
ST-Segment Elevation Myocardial Infarction (STEMI)No-Reflow PhenomenonCoronary Slow Flow+1 more
National Institute of Cardiovascular Diseases, Pakistan 1,148
Post-approval studies (Phase 4)Looking for participantsNCT05427786
What this trial is testing

Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

Who this might be right for
No-Reflow PhenomenonCoronary Artery DiseasePercutaneous Coronary Intervention
Korea University Anam Hospital 458
Large-scale testing (Phase 3)UnknownNCT05739929
What this trial is testing

Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)

Who this might be right for
Coronary Artery Disease
Helwan University 400
Large-scale testing (Phase 3)Looking for participantsNCT05892510
What this trial is testing

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Who this might be right for
Ischemic Stroke, AcuteCerebrovascular DisordersBrain Disorder+1 more
University of Melbourne 462
Post-approval studies (Phase 4)UnknownNCT02233790
What this trial is testing

Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI

Who this might be right for
Myocardial InfarctionNo-Reflow Phenomenon
First Hospital of China Medical University 600
Not applicableStudy completedNCT05355532
What this trial is testing

Genetic Determinants of the Coronary Microvascular Obstruction in PCI

Who this might be right for
Myocardial InfarctionNo-Reflow Phenomenon
Privolzhsky Research Medical University 80
Post-approval studies (Phase 4)Study completedNCT00712894
What this trial is testing

Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction

Who this might be right for
Acute Myocardial InfarctionPercutaneous Coronary Intervention
Fudan University 102
Testing effectiveness (Phase 2)Study completedNCT00604695
What this trial is testing

A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks

Who this might be right for
Acute Myocardial Infarction
C. Michael Gibson, MS, MD 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07195812
What this trial is testing

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

Who this might be right for
ST Elevation Myocardial InfarctionNo-Reflow Phenomenon
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Not applicableUnknownNCT04835207
What this trial is testing

Metabolic Profile as a Predictor of No-reflow in Diabetic Patients

Who this might be right for
Acute Myocardial Infarction (AMI)
El Zahraa Gamal 120
Not applicableUnknownNCT01430884
What this trial is testing

Analysis of Human Coronary Aspirate

Who this might be right for
Coronary ArteriosclerosisCoronary Heart DiseaseNo Reflow Phenomenon
Universität Duisburg-Essen 500
Post-approval studies (Phase 4)Study completedNCT04699110
What this trial is testing

Adrenaline for the Treatment of No-Reflow in Normotensive Patients

Who this might be right for
Acute Coronary SyndromeNo-Reflow PhenomenonNormotensive
National Institute of Cardiovascular Diseases, Pakistan 201
Testing effectiveness (Phase 2)Study completedNCT01747174
What this trial is testing

REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction

Who this might be right for
ST-elevation Myocardial Infarction (STEMI)
University Hospitals, Leicester 247
Not applicableStudy completedNCT02125526
What this trial is testing

Intra-aortic Balloon Pump in Extensive Myocardial Infarction With Persistent Ischemia

Who this might be right for
Acute Myocardial InfarctionPersisting IschemiaNo Reflow
Lokien van Nunen 100
Not applicableEnded earlyNCT04542889
What this trial is testing

Coronary Microcirculation Assessment After Primary Angioplasty in Myocardial Infarction

Who this might be right for
STEMI - ST Elevation Myocardial Infarction
Assistance Publique - Hôpitaux de Paris 31
Not applicableUnknownNCT03406832
What this trial is testing

Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

Who this might be right for
ST Segment Elevation Myocardial InfarctionElective Percutaneous Coronary Intervention
The First Affiliated Hospital of Zhengzhou University 1,000
Post-approval studies (Phase 4)Study completedNCT02054000
What this trial is testing

Intracoronary Tirofiban on No-Reflow Phenomena

Who this might be right for
No-Reflow Phenomenon
TC Erciyes University 162
Next Page